CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-30 | Kendall Keith J CEO and President | Option exercise · Restricted Stock Unit | −14,572 | 87,432 | ||
| 2018-11-27 | BRAENDER LORI J General Counsel | Purchase | +1,000 | $10.57 | $11K | 1,000 |
| 2018-11-27 | Kendall Keith J CEO and President | Purchase | +1,000 | $9.87 | $10K | 621,139 |
| 2018-11-26 | Wood Theresa SVP-HR and Org. Development | Purchase | +500 | $10.34 | $5K | 79,765 |
| 2018-11-23 | Kendall Keith J CEO and President | Purchase | +1,950 | $9.90 | $19K | 620,139 |
| 2018-11-21 | Marshall Ken W. Commercial Leader | Purchase | +1,445 | $10.15 | $15K | 1,445 |
| 2018-11-21 | Schobel Alexander Mark Chief Innovation/Tech Officer | Purchase | +1,000 | $10.25 | $10K | 1,009,229 |
| 2018-11-21 | Maxwell John T. SVP-Chief Financial Officer | Purchase | +10,000 | $9.80 | $98K | 148,614 |
| 2018-11-21 | Kendall Keith J CEO and President | Purchase | +6,000 | $10.17 | $61K | 618,189 |
| 2018-11-21 | Boyd Peter E. SVP-Operations/Value Delivery | Purchase | +200 | $9.98 | $2K | 49,639 |
| 2018-09-30 | Kendall Keith J CEO and President | Option exercise | +329 | 1,008,391 | ||
| 2018-09-30 | Kendall Keith J CEO and President | Shares withheld for taxes | −162 | $17.51 | $3K | 1,008,229 |
| 2018-09-30 | Kendall Keith J CEO and President | Option exercise · Restricted Stock Unit | −329 | 2,307 | ||
| 2018-09-30 | Schobel Alexander Mark Chief Innovation/Tech Officer | Option exercise | +329 | 1,008,391 | ||
| 2018-09-30 | Schobel Alexander Mark Chief Innovation/Tech Officer | Shares withheld for taxes | −162 | $17.51 | $3K | 1,008,229 |
| 2018-09-30 | Schobel Alexander Mark Chief Innovation/Tech Officer | Option exercise · Restricted Stock Unit | −329 | 2,307 | ||
| 2018-09-10 | BRAENDER LORI J SVP, General Counsel | Grant or award · Stock Option (Right to Purchase) | +85,000 | 85,000 | ||
| 2018-08-31 | Kendall Keith J CEO and President | Option exercise | +14,572 | 1,014,572 | ||
| 2018-08-31 | Kendall Keith J CEO and President | Shares withheld for taxes | −6,510 | $18.01 | $117K | 1,008,062 |
| 2018-08-31 | Kendall Keith J CEO and President | Option exercise · Restricted Stock Unit | −14,572 | 102,004 |
Page 22 of 24 · 462 trades